(January 2009)
ISSN 0007-0920
Welcome to BJC
Multidisciplinary Journal of Cancer Research
BJC publishes high quality original papers and reviews that make a significant contribution to increasing understanding of the causes of cancer and to improving the treatment and survival of patients.
BJC is proud of its editorial independence, high standards, and tradition of serving the international cancer research community - we are one of the world's leading general cancer journals.
Impact factor 4.635
Trends and inequalities in survival for 20 cancers in England and Wales 1986-2001: population-based analyses and clinical commentaries
This Cancer Research UK supplement provides important new information and commentary on survival rates for the 20 most common cancers diagnosed in England and Wales over a 14-year period from 1986 to 1999. The analyses are based on data collected by cancer registries on 2.2 million cancer patients. The authors have assessed both trends in survival rates over time and inequalities in survival between groups of patients with different levels of deprivation. The unique pairing of epidemiology and expert clinical analysis should provide a complete picture of the state of cancer survival and cancer care in England and Wales.
Click here to view the supplement.
Archive
Coinciding with the release of the first issue of Volume 99 of BJC on 1st July 2008, and the launch of our new website design, BJC, NPG and Cancer Research UK are pleased to announce that all BJC papers will become freely available to readers of this website, 12 months after they are published.
This applies in the first instance to papers published in and after 1999. Please see our Archive page for the details.
Featured Articles
Antiangiogenic drugs in ovarian cancer
Ethics and biobanks
Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer
Molecular therapy for the treatment of hepatocellular carcinoma
Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial
Identification of paediatric cancer patients with poor quality of life
HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer
Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients
Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment
Mortality and cancer incidence following occupational radiation exposure: third analysis of the National Registry for Radiation Workers
Cancer in the offspring of female radiation workers: a record linkage study
Angiogenesis in pre-malignant conditions
Health-related quality of life and distress in cancer patients: results from a large randomised study
Population screening for colorectal cancer: the implications of an ageing population
Simultaneous blockade of AP-1 and phosphatidylinositol 3-kinase pathway in non-small cell lung cancer cells
KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer
PPAR γ agonists inhibit growth and expansion of CD133+ brain tumour stem cells
Comprehensive analysis of common mitochondrial DNA variants and colorectal cancer risk
